| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |